| JYHZ1900073 | 比卡鲁胺片 | bicalutamide | Tablet | Chemical Drugs | License Renew | 2019-03-28 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd;Corden Pharma GmbH;Astrazeneca Uk Ltd | Certificate Issued | 2019-06-20 | view |
| CYHS1201502 | 比卡鲁胺片 | bicalutamide | Tablet | Chemical Drugs(6) | Generic Drug | 2013-04-22 | 江苏正大天晴药业股份有限公司 | Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd | Certificate Issued | 2016-09-26 | view |
| CYHS0510025 | 比卡鲁胺片 | bicalutamide | Tablet | Chemical Drugs(6) | Generic Drug | 2006-03-01 | 扬子江药业集团有限公司 | Yangtze River Pharmaceutical (Group) Co Ltd | Certificate Issued | 2008-11-12 | view |
| JYHB2002176 | 比卡鲁胺片 | bicalutamide | Tablet | Chemical Drugs | Supplementary Application | 2020-10-29 | 阿斯利康制药有限公司 | Astrazeneca Pharmaceutical Co Ltd;Corden Pharma GmbH;Astrazeneca Uk Ltd | Filed | 2020-11-12 | view |
| JYHB1701506 | 比卡鲁胺片 | bicalutamide | Tablet | Chemical Drugs | Supplementary Application | 2017-11-30 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd;Corden Pharma GmbH;Astrazeneca Uk Ltd | Filed | 2017-12-18 | view |
| JXHL0900360 | 比卡鲁胺片 | bicalutamide | Tablet | Chemical Drugs | Import Drug Application | 2009-11-19 | 泰美德制药集团公司 | Taimeide Pharmaceutical Group Co Ltd | Certificate Issued | 2011-04-18 | view |
| CXL20022261 | 比卡鲁胺片 | bicalutamide | Tablet | Chemical Drugs(4) | New Drug Application | 2002-09-02 | 浙江万马药业有限公司 | Zhejiang Wansheng Pharmaceutical Co Ltd | Certificate Issued | 2004-01-19 | view |
| JYHZ2200172 | 比卡鲁胺片 | bicalutamide | Tablet | Chemical Drugs | License Renew | 2022-07-02 | | Corden Pharma GmbH;Astrazeneca Investment (China) Co Ltd;Astrazeneca Uk Ltd | | | view |
| JYHB1801451 | 比卡鲁胺片 | bicalutamide | Tablet | Chemical Drugs | Supplementary Application | 2018-12-17 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd;Corden Pharma GmbH;Astrazeneca Uk Ltd | Certificate Issued | 2019-02-18 | view |
| JYHB1200153 | 比卡鲁胺片 | bicalutamide | Tablet | Chemical Drugs | Supplementary Application | 2012-03-08 | 阿斯利康制药有限公司 | Astrazeneca Pharmaceutical Co Ltd;Corden Pharma GmbH;Astrazeneca Uk Ltd | Certificate Issued | 2013-04-16 | view |
| CYHB0501537 | 比卡鲁胺片 | bicalutamide | Tablet | Chemical Drugs | Supplementary Application | 2005-06-15 | 上海医药工业研究院 | Shanghai Institute of Pharmaceutical Industry | Certificate Issued | 2005-10-14 | view |
| JYHB2040001 | 比卡鲁胺片 | bicalutamide | Tablet | Chemical Drugs | Supplementary Application | 2020-02-15 | 费森尤斯卡比（中国）投资有限公司 | Fresenius Kabi (China) Company Limited;Fresenius Kabi Oncology Ltd | Certificate Issued | 2021-01-04 | view |
| CYHB1503453 | 比卡鲁胺片 | bicalutamide | Tablet | Chemical Drugs | Supplementary Application | 2015-08-20 | 上海复旦复华药业有限公司 | Shanghai Fudan Forward Pharmaceutical Co Ltd | Certificate Issued | 2016-08-01 | view |
| JXHL0800439 | 比卡鲁胺片 | bicalutamide | Tablet | Chemical Drugs | Import Drug Application | 2008-12-29 | 印度太阳药业有限公司 | Sun Pharmaceutical Industries Ltd | Certificate Issued | 2010-04-20 | view |
| CXL20020055 | 比卡鲁胺片 | bicalutamide | Tablet | Chemical Drugs(4) | New Drug Application | 2002-01-31 | 中科院上海药物研究所 | Shanghai Institute of Materia Medica Chinese Academy of Sciences | Approval Completed-Pending Certificated | 2003-01-30 | view |
| CYHB2150178 | 比卡鲁胺片 | bicalutamide | Tablet | Chemical Drugs(原6) | Supplementary Application | 2021-03-26 | 上海复旦复华药业有限公司 | Shanghai Fudan Forward Pharmaceutical Co Ltd | In Review | 2021-03-25 | view |
| JYHZ1700250 | 比卡鲁胺片 | bicalutamide | Tablet | Chemical Drugs | License Renew | 2018-01-12 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd;Corden Pharma GmbH;Astrazeneca Uk Ltd | Certificate Issued | 2018-01-25 | view |
| JXHR1100007 | 比卡鲁胺片 | bicalutamide | Tablet | Chemical Drugs | State Standards | 2011-07-14 | 泰美德制药集团公司 | Taimeide Pharmaceutical Group Co Ltd | Certificate Issued | 2012-06-06 | view |
| CXL20022035 | 比卡鲁胺片 | bicalutamide | Tablet | Chemical Drugs(4) | New Drug Application | 2004-03-09 | 国家药品监督管理局天津药物研究院 | Tianjin Remedy Research Institute | Certificate Issued | 2004-07-29 | view |
| JYHB2001357 | 比卡鲁胺片 | bicalutamide | Tablet | Chemical Drugs | Supplementary Application | 2020-08-21 | 中文名称:阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd;Corden Pharma GmbH;Astrazeneca Uk Ltd | Filed | 2020-09-09 | view |
